D. E. Shaw & Co., Inc. - CELL THERAPEUTICS INC ownership

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of CELL THERAPEUTICS INC
ValueSharesWeighting
Q1 2014$42,000
-94.9%
12,369
-97.1%
0.00%
-100.0%
Q4 2013$821,000
-2.6%
427,460
-16.9%
0.00%0.0%
Q3 2013$843,000
-22.9%
514,612
-50.6%
0.00%
-50.0%
Q2 2013$1,094,0001,042,6620.00%
Other shareholders
CELL THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
SPHERA FUNDS MANAGEMENT LTD. 400,000$1,360,0000.31%
TFS CAPITAL LLC 1,351,073$4,594,0000.30%
Geduld E E 100,000$340,0000.18%
OXFORD ASSET MANAGEMENT LLP 1,429,215$4,859,0000.14%
EAGLE ASSET MANAGEMENT INC 6,718,484$22,842,0000.13%
First Heartland Consultants, Inc. 74,624$254,0000.12%
WASHINGTON TRUST Co 410,616$1,396,0000.10%
FIRST NEW YORK SECURITIES LLC /NY 50,000$170,0000.08%
Tradeworx Inc. 16,704$57,0000.05%
LMR Partners LLP 103,643$352,0000.05%
View complete list of CELL THERAPEUTICS INC shareholders